Newgenivf Group Limited Stock Analysis
| NIVF Stock | 1.02 0.06 5.56% |
NewGenIvf Group Limited is overvalued with Real Value of 1.04 and Hype Value of 0.77. The main objective of NewGenIvf Group stock analysis is to determine its intrinsic value, which is an estimate of what NewGenIvf Group Limited is worth, separate from its market price. There are two main types of NewGenIvf Group's stock analysis: fundamental analysis and technical analysis.
The NewGenIvf Group stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and NewGenIvf Group's ongoing operational relationships across important fundamental and technical indicators.
NewGenIvf |
NewGenIvf Stock Analysis Notes
The company had not issued any dividends in recent years. NewGenIvf Group had 1:20 split on the 11th of February 2025. To find out more about NewGenIvf Group Limited contact the company at 212-537-4406 or learn more at https://newgenivf.com.NewGenIvf Group Investment Alerts
| NewGenIvf Group generated a negative expected return over the last 90 days | |
| NewGenIvf Group has high historical volatility and very poor performance | |
| NewGenIvf Group has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 5.14 M. Net Loss for the year was (690.85 K) with profit before overhead, payroll, taxes, and interest of 1.48 M. | |
| NewGenIvf Group generates negative cash flow from operations | |
| NewGenIvf Group has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: NIVF stock touches 52-week low at 0.93 amid market challenges By Investing.com - Investing.com South Africa |
NewGenIvf Group Thematic Classifications
In addition to having NewGenIvf Group stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | HealthcareUSA Equities from Healthcare industry as classified by Fama & French |
NewGenIvf Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.69 M.NewGenIvf Profitablity
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.48) | (0.46) | |
| Return On Capital Employed | 0.07 | 0.08 | |
| Return On Assets | (0.48) | (0.46) | |
| Return On Equity | (0.05) | (0.05) |
Management Efficiency
The NewGenIvf Group's current Return On Capital Employed is estimated to increase to 0.08, while Return On Tangible Assets are forecasted to increase to (0.46). At this time, NewGenIvf Group's Debt To Assets are most likely to slightly decrease in the upcoming years. NewGenIvf Group's management efficiency ratios could be used to measure how well NewGenIvf Group manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.07 | 0.06 | |
| Tangible Book Value Per Share | 0.07 | 0.06 | |
| Enterprise Value Over EBITDA | 9.73 | 10.21 | |
| Price Book Value Ratio | 0.17 | 0.18 | |
| Enterprise Value Multiple | 9.73 | 10.21 | |
| Price Fair Value | 0.17 | 0.18 | |
| Enterprise Value | 3.7 M | 4.9 M |
The leadership approach at NewGenIvf Group's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Technical Drivers
As of the 25th of March, NewGenIvf Group secures the Mean Deviation of 9.41, risk adjusted performance of (0.08), and Standard Deviation of 14.19. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NewGenIvf Group, as well as the relationship between them. Please verify NewGenIvf Group market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if NewGenIvf Group Limited is priced some-what accurately, providing market reflects its recent price of 1.02 per share. Given that NewGenIvf Group is a hitting penny stock territory we strongly suggest to closely look at its jensen alpha.NewGenIvf Group Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. NewGenIvf Group middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for NewGenIvf Group. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
NewGenIvf Group Predictive Daily Indicators
NewGenIvf Group intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NewGenIvf Group stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
NewGenIvf Group Forecast Models
NewGenIvf Group's time-series forecasting models are one of many NewGenIvf Group's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NewGenIvf Group's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About NewGenIvf Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how NewGenIvf Group prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NewGenIvf shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NewGenIvf Group. By using and applying NewGenIvf Stock analysis, traders can create a robust methodology for identifying NewGenIvf entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.13) | (0.15) | |
| Operating Profit Margin | 0.01 | 0.01 | |
| Net Loss | (0.13) | (0.15) | |
| Gross Profit Margin | 0.29 | 0.22 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding NewGenIvf Group to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Complementary Tools for NewGenIvf Stock analysis
When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |